ED
WRK

Exane Derivatives’s WestRock Company WRK Stock Holding History

Exane Derivatives’s Portfolio WRK Stock Details WRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,001
Closed -$282K – 1050
2022
Q1 		$282K Buy
+6,001
New +$274K 0.08% 258
2021
Q4 		– Sell
-8,522
Closed -$425K – 1100
2021
Q3 		$425K Buy
+8,522
New +$431K 0.1% 215

Other funds holding WRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GA
Greenhaven Associates Purchase, New York $8.66B AUM 17.37% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Exane Derivatives's WRK Position: Q2 2022 in Review

Exane Derivatives sold out of WestRock Company (WRK) in Q2 2022, closing a stake of 6,001 shares — an estimated $282K sold.

Exane Derivatives first reported a position in WRK in Q3 2021 and held it in 2 quarters. The position peaked at $425K in Q3 2021. 606 funds tracked by Wall St. Rank hold WRK as of Q2 2022.

  • Exane Derivatives reported no remaining WestRock Company position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 6,001 WestRock Company shares in Q2 2022, an estimated $282K.
  • Exane Derivatives first reported a position in WestRock Company in Q3 2021 and held it in 2 quarters.
  • Exane Derivatives's WestRock Company position peaked at $425K in Q3 2021.
  • 606 funds tracked by Wall St. Rank held WestRock Company as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.